Breaking News
recent

Machine learning algorithms could predict breast cancer treatment responses.



 A data-centric branch of artificial intelligence may take the guesswork out of selecting the appropriate chemotherapy treatment for breast cancer patients 
Patients with the same type of breast cancer can have different responses to the same medication, which leaves doctors on a tough spot; how will they know which treatment will have the best response? If they get it right, their patients may enter remission, but if they are wrong their patient’s health will deteriorate.
 Researchers have been trying to find the answer of this problem; and now researchers at western University might have the answer. They developed a machine learning algorithms, a branch of artificial intelligence, that crunch genetic data to determine the most likely treatment response and allow personalized treatment regimens.
“Artificial intelligence is a powerful tool for predicting drug outcomes because it looks at the sum of all interacting genes,” said lead researcher peter Rogan. “The earlier we treat a patient with the most effective medication, the more likely we can effectively treat or possibly even cure that patient.”
The researchers used a set of 40 genes that are found in 90 percent of breast cancer tumors for their analysis of data from cell lines and tumor tissue samples from around 350 cancer patients who were treated with at least one of the two chemotherapy drugs paclitaxel  and gemcitabine.
They then set their computers to work crunching the data and identifying associations between the drug and patient genes. Their machine learning tool managed to predict gemcitabine resistance and paclitaxel sensitivity with 84 percent accuracy and gemcitabine response with 62 to 71 percent accuracy.
The researchers now plan to refine their algorithms and feed the system more data to improve their predictions.
This is not the first case of machine learning being used to help cancer treatment. A new company called Deep Genomics founded earlier this year to identify never seen gene variants and mutation in various disease including cancer, by pitting computers against large data sets.

Source: Gizmag
Content maybe edited for content and length.
Ed Tesla

Ed Tesla

No comments:

infolink

Copyright SmartPlanet. Powered by Blogger.